Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
about
(1→3)β-D-glucan testing for the detection of invasive fungal infections in immunocompromised patientsβ-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida speciesUse and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot studyClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipientsManagement of invasive candidiasis in nonneutropenic ICU patients.The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studiesβ-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children(1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort StudyContribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditionsUtility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.(1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?Diagnosis and treatment of aspergillosis in children.Early treatment of candidemia in adults: a review.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.New fungal diagnostics.Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.Non-cultural methods for the diagnosis of invasive fungal disease.Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.The Predictive Value of Coefficient of PCT × BG for Anastomotic Leak in Esophageal Carcinoma Patients With ARDS After Esophagectomy.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.(1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study.How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.Lack of 1-3-B-D-glucan detection in adults with bacteraemia.Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.β-D-glucan testing is important for diagnosis of invasive fungal infections.Reactivity of the 1,3-β-D-glucan assay during bacteraemia: limited evidence from a prospective study.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Recent progress in the management of invasive fungal infections in hematopoietic stem cell transplant recipients. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), March 30-April 2, 2008, Florence, Italy.Correlation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapy.Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies
P2860
Q24198039-3EE24E12-FE5F-4DE4-A42D-D561ED329224Q26825753-522A0650-0215-4448-B406-9A05EDCD7FCDQ33711043-5EEDF914-F8E3-4C01-9009-4EFBED1A3759Q33900089-A60E6E50-585C-4BBC-AA0D-C9BFB5107EF1Q34260841-B3300965-3EBB-43F0-961D-A69E7D6C975DQ34374081-B38908D3-FF76-4DB9-9A54-0B2928F09A59Q34505582-0E8D6E20-5E05-40AE-A1CD-0B51420424F8Q34739041-5A92D7E3-4A44-4A73-8DE9-55CAB9C3A4DBQ35122093-B6394939-D444-410C-B73D-202354F334F3Q35683091-EDAF2FE8-867A-4376-925A-DD9766B6F297Q35868758-E167DEE8-352F-4D63-B182-D0B31DA790DCQ36437449-E4FE252E-9232-4438-A99D-47DCD0D62A17Q36620865-A8D49C01-7ED2-4807-BC51-2643803AA85FQ36630700-200E31E7-5A32-4349-9D19-72B7FFC0CCB8Q36822948-CB5540B0-6576-4031-87F8-8E3800BEA0E9Q36902916-15FFB468-84D9-4FAD-8D74-7E49FD80E770Q37051568-FD6E9424-CFFD-4FF4-805B-C9BA22A040D0Q37304283-178EEA6A-261F-4A03-8F5D-703109D4AC2AQ37463228-E1B40B6F-BA41-457F-9A12-9C77962BB3FEQ37785541-DAF1ACCB-A437-4516-BA31-99AD4411A597Q37854718-BAECC922-26D5-4911-9AFA-75D37C5D5444Q37934487-ED4C64AB-9C78-425E-89C8-2CE45E4B62E3Q38231463-1376F3EB-7587-4E17-8FEB-37EE4AE041B9Q38262058-415BECB4-9687-4E73-BA84-AF7FD4C449ECQ38266817-8A769EB7-F8B8-49DA-923A-0EC9B0CC79A7Q38272463-3BCE2700-2931-4A76-899D-AF77D78A13A5Q38679742-2E543F48-05E2-42E7-97CA-772B1198E090Q38795527-E1EA41AB-2E61-462A-B55F-7CE4444EA5F5Q39367519-C3CB9B6F-4910-4EE9-8A0E-3190329E807FQ41128217-888F1813-1416-4CFB-AB38-7518DDABAB86Q41349103-4BB1E6EB-CF85-4C4A-8B62-CB33D4815176Q41554076-57D90EB8-8D2F-4079-89B8-C6BBCC3B3277Q41581027-F68B22EC-C210-47C3-BA4C-89F10A7FD69AQ41740943-4BCAC3D7-DD98-4D22-9206-F3C05090FA95Q41867984-2896EAEA-122B-43D0-BB77-8D897AC73AA1Q49168543-ECF4DE65-3963-4C7D-B5D3-0DB66261D4DFQ50072321-0079D944-EBB5-4851-962D-92DB399FD8A2Q51122976-98DDACAC-1A33-4E60-A324-78268F77E165Q51159025-88E4900C-F7E5-485D-828F-23461B6410CEQ58757779-26504E56-5EF6-4895-A67C-6F913A717B8D
P2860
Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Assessment of the clinical uti ...... persistent neutropenic fever.
@en
type
label
Assessment of the clinical uti ...... persistent neutropenic fever.
@en
prefLabel
Assessment of the clinical uti ...... persistent neutropenic fever.
@en
P2093
P356
P1476
Assessment of the clinical uti ...... persistent neutropenic fever.
@en
P2093
Basel Al-Ramadi
Hussein Ali-Zadeh
Jorgen Kristensen
Lena Klingspor
Malcolm Finkelman
Michael Ellis
Ulla Hedstrom
P304
P356
10.1099/JMM.0.47479-0
P577
2008-03-01T00:00:00Z